A Comparative Evaluation of Concomitant Chemoradiation with Weekly Cisplatin and Erlotinib versus Concomitant Chemoradiation with Weekly Cisplatin in Management of Locally Advanced Carcinoma Cervix
Journal Title: Journal of Medical Science And clinical Research - Year 2018, Vol 6, Issue 12
Abstract
Purpose: The purpose was to compare feasibility, tolerability, toxicity and local control of concomitant chemoradiation with weekly cisplatin and erlotinib versus concomitant chemoradiation with weekly cisplatin in EGFR positive locally advanced carcinoma cervix. Material and Methods: In this prospective, comparative study, 60 histopathologically proven locally advanced carcinoma cervix patients with EGFR positivity received either Erlotinib (150 mg/day) with concomitant chemoradiation (study group) or CCRT (control group). Treatment with CCRT included cisplatin 40 mg/m2 intravenously weekly concurrently with external beam radiation(50 Gy in 25 fractions over 5 weeks) followed by intracavitary HDR brachytherapy (7Gy to point A three times, once in a week). Tumor response was calculated as per the WHO criteria. The treatment induced toxicity such as anaemia, leucopenia and nausea/vomiting were graded as per WHO criteria. Skin reaction, diarrhea and genioturinary toxicity were graded as per RTOG criteria. Results: Overall, complete response was seen in 93% in study group and 86% in control group at the end of treatment. In stage IIB and IIIA, complete response was observed in 100% of patients in the study and control group. Sixty percent patients with stage IIIB in study group and control group had complete response. Forty percent patients with stage IIIB in two groups showed partial response. At last follow up, 93% patients in study group and 80% patients in control group were observed to be free of disease. There were 7% and 10% patients with residual disease in study group and control group respectively. Distant recurrence was seen in 10% patients in control group. Even though response was better in study group but the difference in two groups was not statistically significant. The toxicities commonly encountered in both the treatment groups were majority of Grade I/II. A higher incidence of nausea, vomiting, diarrhea and skin rash was noted in the Erlotinib plus CCRT group in comparison CRT. No Grades 4 and 5 toxicity was observed in Erlotinib with CCRT. Erlotinib was observed to be safe with manageable toxicity profile. Conclusion: Addition of Erlotinib to standard cisplatin-based CCRT showed improved tumor response in comparison to cisplatin-based CRT alone in treatment of locally advanced carcinoma cervix, although not statistically significant with manageable toxicity.
Authors and Affiliations
Dr Jyoti Pannu
Keywords
Related Articles
- EP ID EP506679
- DOI -
- Views 70
- Downloads 0
Impact of various teaching tools on learning in Pharmacology: a crosssectional study among second year M.B.B.S students
Background: Our study aims to assess and compare the impact of teaching tools like chalk and talk method and power point presentation on different areas of learning in pharmacology. Methods: This cross sectional question...
Clinico-Heamatological Study of Dengue in Adults and the Significance of Total Leukocyte Count in Management of Dengue
Background: Dengue is the most rapidly spreading mosquito borne viral disease in the world. There is an increase in incidence of dengue in adult population in South Asian countries in recent years. Objective: To study th...
Neonatal Liver Biopsy- Experience from a Tertiary Care Centre
Objectives: To clinch the diagnosis of complex neonatal liver diseases (where all other diagnostic modalities fail) this study was conducted in a Tertiary Care Centre of Northern India. Materials and Methods: The neonate...
Evaluation of various closure techniques after laparotomy
Introduction: Every operation requires one of closure techniques to close the wound for subsequent successful healing, proper closing of wound influence the success of surgery. Many complications such as infection, wound...
A Study to Determine the Clinical Efficacy of Spinal Facet Joint Intervention with Medial Branch Block in Patients of Chronic Low Back Pain with Radiation Associated with Facet Arthropathy
Facetogenic back pain results from involvement of spinal zygapophyseal or facet joints. The common symptoms are diffuse back pain, localized tenderness at facet joints, reduced functionality. Lumbar radiculopathy due to...